Literature DB >> 27521117

Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System.

Kenar D Jhaveri1, Vipulbhai Sakhiya2, Rimda Wanchoo2, Daniel Ross2, Steven Fishbane2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27521117     DOI: 10.1016/j.kint.2016.06.027

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

Review 1.  Management of nephrotoxicity of chemotherapy and targeted agents: 2020.

Authors:  Varsha Chiruvella; Pavan Annamaraju; Achuta K Guddati
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition.

Authors:  Yuntao Bai; Ji Young Kim; Bijay Bisunke; Laura A Jayne; Josie A Silvaroli; Michael S Balzer; Megha Gandhi; Kevin M Huang; Veronika Sander; Jason Prosek; Rachel E Cianciolo; Sharyn D Baker; Alex Sparreboom; Kenar D Jhaveri; Katalin Susztak; Amandeep Bajwa; Navjot Singh Pabla
Journal:  Kidney Int       Date:  2021-09-15       Impact factor: 18.998

Review 3.  Hypomagnesemia in the Cancer Patient.

Authors:  Biruh T Workeneh; Nupur N Uppal; Kenar D Jhaveri; Helbert Rondon-Berrios
Journal:  Kidney360       Date:  2020-11-11

Review 4.  Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.

Authors:  Kenar D Jhaveri; Rimda Wanchoo; Vipulbhai Sakhiya; Daniel W Ross; Steven Fishbane
Journal:  Kidney Int Rep       Date:  2016-09-21

5.  BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon.

Authors:  Michele Stanchina; Zoe McKinnell; Jae H Park; Eytan M Stein; Sheng F Cai; Justin Taylor
Journal:  Leuk Res Rep       Date:  2020-06-08

Review 6.  Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients.

Authors:  Yuanyuan Fu; Chengheng Liao; Kai Cui; Xiao Liu; Wentong Fang
Journal:  Ther Adv Med Oncol       Date:  2019-09-23       Impact factor: 8.168

7.  Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy.

Authors:  Samy Hakroush; Svenja Wulf; Julia Gallwas; Björn Tampe
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

Review 8.  Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI.

Authors:  Letizia De Chiara; Gianmarco Lugli; Gianluca Villa; Valentina Raglianti; Faeq Husain-Syed; Fiammetta Ravaglia; Paola Romagnani; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

Review 9.  Management of acute kidney injury in gastrointestinal tumor: An overview.

Authors:  Yi-Qi Su; Yi-Yi Yu; Bo Shen; Feng Yang; Yu-Xin Nie
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.